XML 35 R22.htm IDEA: XBRL DOCUMENT
v3.10.0.1

FINANCIAL INSTRUMENTS | 12 Months Ended
--- | ---
Oct. 31, 2018
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
FINANCIAL INSTRUMENTS |
13 | FINANCIAL INSTRUMENTS
Concentrations of Credit Risk Financial instruments, which potentially subject the company to concentrations of credit risk, consist principally of accounts receivable that are concentrated in the Professional and Residential business segments. The credit risk associated with these segments is limited because of the large number of customers in the company's customer base and their geographic dispersion, except for the Residential segment that has significant sales to The Home Depot. Derivative Instruments and Hedging Activities Risk Management Objective of Using Derivatives The company is exposed to foreign currency exchange rate risk arising from transactions in the normal course of business, such as sales to third party customers, sales and loans to wholly owned foreign subsidiaries, foreign plant operations, and purchases from suppliers. The company’s primary currency exchange rate exposures are with the Euro, the Australian dollar, the Canadian dollar, the British pound, the Mexican peso, the Japanese yen, the Chinese Renminbi, and the Romanian New Leu against the U.S. dollar, as well as the Romanian New Leu against the Euro. To reduce its exposure to foreign currency exchange rate risk, the company actively manages the exposure of its foreign currency exchange rate risk by entering into various derivative instruments to hedge against such risk, authorized under company policies that place controls on these hedging activities, with counterparties that are highly rated financial institutions. The company’s policy does not allow the use of derivative instruments for trading or speculative purposes. The company has also made an accounting policy election to use the portfolio exception with respect to measuring counterparty credit risk for derivative instruments, and to measure the fair value of a portfolio of financial assets and financial liabilities on the basis of the net open risk position with each counterparty. The company’s hedging activities primarily involve the use of forward currency contracts to hedge most foreign currency transactions, including forecasted sales and purchases denominated in foreign currencies. The company uses derivative instruments only in an attempt to limit underlying exposure from foreign currency exchange rate fluctuations and to minimize earnings and cash flow volatility associated with foreign currency exchange rate fluctuations. Decisions on whether to use such derivative instruments are primarily based on the amount of exposure to the currency involved and an assessment of the near-term market value for each currency. The company recognizes all derivative instruments at fair value on the Consolidated Balance Sheets as either assets or liabilities. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as a cash flow hedging instrument. Cash Flow Hedging Instruments The company formally documents relationships between cash flow hedging instruments and the related hedged transactions, as well as its risk-management objective and strategy for undertaking cash flow hedging instruments. This process includes linking all cash flow hedging instruments to the forecasted transactions, such as sales to third parties, foreign plant operations, and purchases from suppliers. At the cash flow hedge’s inception and on an ongoing basis, the company formally assesses whether the cash flow hedging instruments have been highly effective in offsetting changes in the cash flows of the hedged transactions and whether those cash flow hedging instruments may be expected to remain highly effective in future periods. Changes in the fair values of the spot rate component of outstanding, highly effective cash flow hedging instruments included in the assessment of hedge effectiveness are recorded in other comprehensive income within AOCL on the Consolidated Balance Sheets and are subsequently reclassified to net earnings within the Consolidated Statements of Earnings during the same period in which the cash flows of the underlying hedged transaction affect net earnings. Changes in the fair values of hedge components excluded from the assessment of effectiveness are recognized immediately in net earnings under the mark-to-market approach. The classification of gains or losses recognized on cash flow hedging instruments and excluded components within the Consolidated Statements of Earnings is the same as that of the underlying exposure. Results of cash flow hedging instruments, and the related excluded components, of sales and foreign plant operations are recorded in net sales and cost of sales, respectively. The maximum amount of time the company hedges its exposure to the variability in future cash flows for forecasted trade sales and purchases is two years. Results of cash flow hedges of intercompany loans are recorded in other income, net as an offset to the remeasurement of the foreign loan balance. When it is determined that a derivative instrument is not, or has ceased to be, highly effective as a cash flow hedge, the company discontinues cash flow hedge accounting prospectively. The gain or loss on the dedesignated derivative instrument remains in AOCL and is reclassified to net earnings within the same Consolidated Statements of Earnings line item as the underlying exposure when the forecasted transaction affects net earnings. When the company discontinues cash flow hedge accounting because it is no longer probable, but it is still reasonably possible that the forecasted transaction will occur by the end of the originally expected period or within an additional two-month period of time thereafter, the gain or loss on the derivative instrument remains in AOCL and is reclassified to net earnings within the same Consolidated Statements of Earnings line item as the underlying exposure when the forecasted transaction affects net earnings. However, if it is probable that a forecasted transaction will not occur by the end of the originally specified time period or within an additional two-month period of time thereafter, the gains and losses that were in AOCL are immediately recognized in net earnings within other income, net in the Consolidated Statements of Earnings. In all situations in which cash flow hedge accounting is discontinued and the derivative instrument remains outstanding, the company carries the derivative instrument at its fair value on the Consolidated Balance Sheets, recognizing future changes in the fair value within other income, net in the Consolidated Statements of Earnings. As of October 31, 2018, the notional amount outstanding of forward contracts designated as cash flow hedging instruments was $245.0 million. Derivatives Not Designated as Cash Flow Hedging Instruments The company also enters into foreign currency contracts that include forward currency contracts to mitigate the remeasurement of specific assets and liabilities on the Consolidated Balance Sheets. These contracts are not designated as cash flow hedging instruments. Accordingly, changes in the fair value of hedges of recorded balance sheet positions, such as cash, receivables, payables, intercompany notes, and other various contractual claims to pay or receive foreign currencies other than the functional currency, are recognized immediately in other income, net, on the Consolidated Statements of Earnings together with the transaction gain or loss from the hedged balance sheet position. The following table presents the fair value and location of the company’s derivative instruments on the Consolidated Balance Sheets (in thousands):
Fair Value as of October 31 |  | 2018 |  | 2017
Derivative assets: |  |  |  |  |  |
Derivatives designated as cash flow hedging instruments: |  |  |  |  |  |
Prepaid expenses and other current assets |  |  |  |  |  |
Forward currency contracts |  | $ | 8,596 |  |  | $ | 1,014 |
Derivatives not designated as cash flow hedging instruments: |  |  |  |  |  |
Prepaid expenses and other current assets |  |  |  |  |  |
Forward currency contracts |  | 2,305 |  |  | 27 |
Total assets |  | $ | 10,901 |  |  | $ | 1,041 |
Derivative liabilities: |  |  |  |  |  |
Derivatives designated as cash flow hedging instruments: |  |  |  |  |  |
Accrued liabilities |  |  |  |  |  |
Forward currency contracts |  | $ | — |  |  | $ | 1,563 |
Derivatives not designated as cash flow hedging instruments: |  |  |  |  |  |
Accrued liabilities |  |  |  |  |  |
Forward currency contracts |  | 13 |  |  | 703 |
Total liabilities |  | $ | 13 |  |  | $ | 2,266 |
The company entered into an International Swap Dealers Association ("ISDA") Master Agreement with each counterparty that permits the net settlement of amounts owed under their respective contracts. The ISDA Master Agreement is an industry standardized contract that governs all derivative contracts entered into between the company and the respective counterparty. Under these master netting agreements, net settlement generally permits the company or the counterparty to determine the net amount payable or receivable for contracts due on the same date or in the same currency for similar types of derivative transactions. The company records the fair value of its derivative instruments at the net amount in its Consolidated Balance Sheets. The following table shows the effects of the master netting arrangements on the fair value of the company’s derivative instruments that are recorded in the Consolidated Balance Sheets (in thousands):
Fair Value as of October 31 |  | 2018 |  | 2017
Derivative assets: |  |  |  |  |  |
Forward currency contracts: |  |  |  |  |  |
Gross amounts of recognized assets |  | $ | 10,901 |  |  | $ | 1,055 |
Gross liabilities offset in the Consolidated Balance Sheets |  | — |  |  | (14 | )
Net amounts of assets presented in the Consolidated Balance Sheets |  | $ | 10,901 |  |  | $ | 1,041 |
Derivative liabilities: |  |  |  |  |  |
Forward currency contracts: |  |  |  |  |  |
Gross amounts of recognized liabilities |  | $ | (13 | ) |  | $ | (2,266 | )
Gross assets offset in the Consolidated Balance Sheets |  | — |  |  | — |
Net amounts of liabilities presented in the Consolidated Balance Sheets |  | $ | (13 | ) |  | $ | (2,266 | )
The following table presents the impact and location of the amounts reclassified from AOCL into net earnings on the Consolidated Statements of Earnings and the impact of derivative instruments on the Consolidated Statements of Comprehensive Income for the company's derivatives designated as cash flow hedging instruments (in thousands):
|  | Gain (Loss) Reclassified from AOCL into Income |  | Gain (Loss) Recognized in OCI on Derivatives
Fiscal Years Ended October 31 |  | 2018 |  | 2017 |  | 2018 |  | 2017
Derivatives designated as cash flow hedging instruments: |  |  |  |  |  |  |  |
Forward currency contracts: |  |  |  |  |  |  |  |
Net sales |  | $ | (2,914 | ) |  | $ | 1,547 |  |  | $ | 7,008 |  |  | $ | (2,007 | )
Cost of sales |  | 988 |  |  | (1,156 | ) |  | 132 |  |  | 1,849 |
Total derivatives designated as cash flow hedging instruments |  | $ | (1,926 | ) |  | $ | 391 |  |  | $ | 7,140 |  |  | $ | (158 | )
During fiscal 2018 and 2017, the company recognized immaterial gains within other income, net due to the discontinuance of cash flow hedge accounting on forward currency contracts designated as cash flow hedging instruments. As of October 31, 2018, the company expects to reclassify approximately $5.4 million of gains from AOCL to earnings during the next twelve months. The following tables present the impact and location of derivative instruments on the Consolidated Statements of Earnings for the company’s derivatives designated as cash flow hedging instruments and the related components excluded from effectiveness testing (in thousands):
|  | Gain (Loss) Recognized in Earnings on Cash Flow Hedging Instruments
Fiscal Year Ended October 31, 2018 |  | Net Sales |  | Cost of Sales |  | Other Income, Net
Total Consolidated Statements of Earnings income (expense) amounts in which the effects of cash flow hedging instruments are recorded |  | $ | 2,618,650 |  |  | $ | (1,677,639 | ) |  | $ | 18,408 |
Gain (loss) on derivatives designated as cash flow hedging instruments: |  |  |  |  |  |
Forward currency contracts: |  |  |  |  |  |
Amount of gain (loss) reclassified from AOCL into earnings |  | (2,914 | ) |  | 988 |  |  | — |
Gain (loss) on components excluded from effectiveness testing recognized in earnings based on changes in fair value |  | $ | 490 |  |  | $ | (369 | ) |  | $ | — |
|  | Gain (Loss) Recognized in Earnings on Cash Flow Hedging Instruments
Fiscal Year Ended October 31, 2017 |  | Net Sales |  | Cost of Sales |  | Other Income, Net
Total Consolidated Statements of Earnings income (expense) amounts in which the effects of cash flow hedging instruments are recorded |  | $ | 2,505,176 |  |  | $ | (1,584,339 | ) |  | $ | 17,187 |
Gain (loss) on derivatives designated as cash flow hedging instruments: |  |  |  |  |  |
Forward currency contracts: |  |  |  |  |  |
Amount of gain (loss) reclassified from AOCL into earnings |  | 1,547 |  |  | (1,156 | ) |  | — |
Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value |  | $ | — |  |  | $ | — |  |  | $ | 231 |
The following table presents the impact and location of derivative instruments on the Consolidated Statements of Earnings for the company’s derivatives not designated as cash flow hedging instruments (in thousands):
Fiscal Years Ended October 31 |  | 2018 |  | 2017
Gain (loss) on derivative instruments not designated as cash flow hedging instruments: |  |  |  |
Forward currency contracts: |  |  |  |
Other income, net |  | $ | 2,930 |  |  | $ | (4,251 | )
Total gain (loss) on derivatives not designated as cash flow hedging instruments |  | $ | 2,930 |  |  | $ | (4,251 | )

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration